JENNIFER SIEGEL: Open Payments
NPI 1104809268 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 49 payments from 19 companies in 2025. Trend: 2023 $1,233 · 2024 $1,438 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $193 |
| PFIZER INC. | 5 | $97 |
| Astellas Pharma US Inc | 4 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Lundbeck LLC | 3 | $62 |
| Seqirus USA Inc | 3 | $51 |
| Lilly USA, LLC | 2 | $35 |
| Abbott Laboratories | 2 | $29 |
| Organon LLC | 2 | $28 |
Products named: VRAYLAR, PREVNAR 20, Veozah, XIFAXAN, REXULTI, AIRSUPRA, UBRELVY, MOUNJARO.
Industry payments across TX — which companies pay providers there.
